202 related articles for article (PubMed ID: 26828124)
1. Evaluation of Aqueous Flare Levels Following Intravitreal Ranibizumab Injection for Neovascular Age-related Macular Degeneration.
Uzun A; Yalcindag FN; Demirel S; Batýoðlu F; Ozmert E
Ocul Immunol Inflamm; 2017 Apr; 25(2):229-232. PubMed ID: 26828124
[TBL] [Abstract][Full Text] [Related]
2. Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study.
Demirel S; Bilici S; Batıoğlu F; Özmert E
Ophthalmic Res; 2016; 56(1):35-40. PubMed ID: 27027523
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.
Motohashi R; Noma H; Yasuda K; Kotake O; Goto H; Shimura M
Ophthalmic Res; 2017; 58(4):209-216. PubMed ID: 28796997
[TBL] [Abstract][Full Text] [Related]
4. Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration.
Muether PS; Hermann MM; Dröge K; Kirchhof B; Fauser S
Am J Ophthalmol; 2013 Nov; 156(5):989-993.e2. PubMed ID: 23938122
[TBL] [Abstract][Full Text] [Related]
5. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
6. Aqueous vascular endothelial growth factor and ranibizumab concentrations after monthly and bimonthly intravitreal injections of ranibizumab for age-related macular degeneration.
Wang X; Sawada T; Kakinoki M; Miyake T; Kawamura H; Saishin Y; Liu P; Ohji M
Graefes Arch Clin Exp Ophthalmol; 2014 Jul; 252(7):1033-9. PubMed ID: 24196779
[TBL] [Abstract][Full Text] [Related]
7. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
Shin JY; Kwon KY; Byeon SH
Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
[TBL] [Abstract][Full Text] [Related]
8. Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration.
Yun C; Oh J; Choi KE; Hwang SY; Kim SW; Huh K
BMC Ophthalmol; 2016 Mar; 16():25. PubMed ID: 26951107
[TBL] [Abstract][Full Text] [Related]
9. Effect of posterior vitreous detachment on aqueous humor level of vascular endothelial growth factor in exudative age-related macular degeneration patients.
Nomura Y; Takahashi H; Tan X; Fujino Y; Kawashima H; Yanagi Y
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):53-7. PubMed ID: 25863675
[TBL] [Abstract][Full Text] [Related]
10. ANGIOPOIETIN-LIKE 4 CORRELATES WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kim JH; Shin JP; Kim IT; Park DH
Retina; 2018 Mar; 38(3):523-530. PubMed ID: 28151839
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW
Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082
[TBL] [Abstract][Full Text] [Related]
12. Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration.
Fauser S; Viebahn U; Muether PS
Acta Ophthalmol; 2015 Dec; 93(8):734-8. PubMed ID: 26016605
[TBL] [Abstract][Full Text] [Related]
13. Correlation between anterior chamber flare changes and diabetic macular edema after intravitreal injection of ranibizumab and aflibercept.
Shiraya T; Kure K; Araki F; Kato S; Kaiya T
Jpn J Ophthalmol; 2020 May; 64(3):250-256. PubMed ID: 32108920
[TBL] [Abstract][Full Text] [Related]
14. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.
Muether PS; Hermann MM; Viebahn U; Kirchhof B; Fauser S
Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670
[TBL] [Abstract][Full Text] [Related]
16. Choroidal blood flow after the first intravitreal ranibizumab injection in neovascular age-related macular degeneration patients.
Mottet B; Aptel F; Geiser MH; Hera R; Zhou T; Almanjoumi A; Vinh V; Chiquet C
Acta Ophthalmol; 2018 Nov; 96(7):e783-e788. PubMed ID: 30203609
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degeneration.
Mendrinos E; Mangioris G; Papadopoulou DN; Donati G; Pournaras CJ
Acta Ophthalmol; 2013 May; 91(3):e184-90. PubMed ID: 23590391
[TBL] [Abstract][Full Text] [Related]
18. Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medications.
Blaha GR; Brooks NO; Mackel CE; Pani A; Stewart AP; Price LL; Barouch FC; Chang J; Marx JL
Retina; 2015 Mar; 35(3):577-81. PubMed ID: 25158942
[TBL] [Abstract][Full Text] [Related]
19. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
[TBL] [Abstract][Full Text] [Related]
20. Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration.
Lee KH; Chin HS; Kim NR; Moon YS
Korean J Ophthalmol; 2015 Dec; 29(6):396-403. PubMed ID: 26635456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
